Schroder UK sells its stake in Kymab Group to Sanofi for $82 million
LONDON: Schroder UK Public Private Trust (SUPP) has sold of its shares in Kymab Group Ltd. to Sanofi against initial proceeds of approximately US$82 million. Furthermore, the SUPP has the potential for additional contingent payments of up to US$33 million…